Yu-Chen Cheng Selected Research

fatty acid-binding protein 6

2/2022	Fatty Acid Binding Protein 6 Inhibition Decreases Cell Cycle Progression, Migration and Autophagy in Bladder Cancers.
10/2021	Inhibition of FABP6 Reduces Tumor Cell Invasion and Angiogenesis through the Decrease in MMP-2 and VEGF in Human Glioblastoma Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Chen Cheng Research Topics

Disease

10	Neoplasms (Cancer) 05/2022 - 01/2016
7	Glioblastoma (Glioblastoma Multiforme) 10/2021 - 01/2016
5	Glioma (Gliomas) 01/2018 - 01/2016
3	Urinary Bladder Neoplasms (Bladder Cancer) 05/2022 - 01/2020
3	Stroke (Strokes) 10/2020 - 01/2017
2	Head and Neck Neoplasms (Head and Neck Cancer) 06/2022 - 12/2011
2	Hemorrhage 05/2022 - 12/2018
2	Atrial Fibrillation 05/2022 - 01/2022
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2022 - 09/2020
1	Stomatitis 06/2022
1	Heart Failure 05/2022
1	Myocardial Infarction 05/2022
1	Migraine Disorders (Migraine) 02/2022
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2021
1	Colorectal Neoplasms (Colorectal Cancer) 10/2021
1	Influenza in Birds (Avian Flu) 01/2021
1	Laryngeal Neoplasms (Laryngeal Cancer) 09/2020
1	Brain Injuries (Brain Injury) 05/2020
1	Carcinoma (Carcinomatosis) 01/2020
1	Sarcopenia 05/2019
1	Muscular Atrophy (Muscle Atrophy) 05/2019
1	Atrophy 05/2019
1	Chronic Renal Insufficiency 05/2019
1	Ischemia 12/2018
1	Thyroid Neoplasms (Thyroid Cancer) 04/2017
1	Obesity 01/2017
1	Inflammation (Inflammations) 01/2017
1	Brain Neoplasms (Brain Tumor) 01/2017
1	Vascular Diseases (Vascular Disease) 01/2017
1	Diabetes Mellitus 01/2017
1	Atherosclerosis 01/2017
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2017
1	Infections 10/2016
1	Bacteremia 10/2016
1	Ischemic Stroke 01/2016
1	Polymyositis 05/2015
1	Colonic Neoplasms (Colon Cancer) 12/2011
1	Melanoma (Melanoma, Malignant) 12/2011
1	Leukoencephalopathies 12/2011
1	Hypersensitivity (Allergy) 04/2011

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2017
4	Temozolomide (Temodar)FDA LinkGeneric 10/2021 - 05/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2022 - 11/2020
3	magnololIBA 01/2020 - 05/2016
2	Bile Acids and Salts (Bile Acids)IBA 05/2022 - 10/2021
2	Messenger RNA (mRNA)IBA 05/2022 - 05/2019
2	Proteasome Endopeptidase Complex (Proteasome)IBA 05/2022 - 05/2019
2	fatty acid-binding protein 6IBA 02/2022 - 10/2021
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2021 - 11/2020
2	honokiolIBA 01/2020 - 05/2016
2	Myosin Light Chains (Myosin Essential Light Chain)IBA 05/2019 - 01/2018
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 05/2022
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 05/2022
1	Dabigatran FDA Link 05/2022
1	salicylhydroxamic acid (SHAM)IBA 02/2022
1	Cisplatin (Platino)FDA LinkGeneric 02/2022
1	Carrier Proteins (Binding Protein)IBA 10/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Hemagglutinins (Hemagglutinin)IBA 01/2021
1	Small Interfering RNA (siRNA)IBA 11/2020
1	wendanIBA 05/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Uremic ToxinsIBA 05/2019
1	IndicanIBA 05/2019
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 12/2018
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2018
1	TRPC3 cation channelIBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2017
1	15-deoxyprostaglandin J2IBA 04/2017
1	carp gonadotropinIBA 04/2017
1	NucleosidesIBA 01/2017
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2017
1	Hematoxylin (Haematoxylon)IBA 01/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2017
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2017
1	PolyphenolsIBA 01/2017
1	cordycepinIBA 01/2017
1	SodiumIBA 10/2016
1	Glucose (Dextrose)FDA LinkGeneric 10/2016
1	C-Reactive ProteinIBA 10/2016
1	Cyclin-Dependent Kinase 2IBA 05/2016
1	Cyclin AIBA 05/2016
1	Caffeine (No Doz)FDA LinkGeneric 01/2016
1	Cathepsin BIBA 01/2016
1	AnthelminticsIBA 12/2011
1	Immunologic Factors (Immunomodulators)IBA 12/2011
1	Levamisole (Decaris)FDA Link 12/2011

Therapy/Procedure

9	Therapeutics 01/2022 - 05/2015
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 11/2021 - 05/2015
1	Radiotherapy 06/2022
1	Aftercare (After-Treatment) 05/2022
1	Transcranial Magnetic Stimulation 02/2022
1	Stents 01/2022
1	Thrombectomy 09/2020
1	Critical Care (Surgical Intensive Care) 05/2020
1	Percutaneous Coronary Intervention 12/2018
1	Drug Therapy (Chemotherapy) 12/2011